| Alkem Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 539523 |
NSE Symbol : ALKEM |
P/E(TTM) : 28.40 |
|
ISIN Demat : INE540L01014 |
Div & Yield% : 0.86 |
EPS(TTM) : 185.12 |
|
Book Value(₹) : 1,142.87 |
Market Cap(₹Cr) : 62,864.29 |
Face Value(₹) : 2.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,491.27 | 2,542.03 | 2,372.17 | 2,044.94 | 2,286.83 | 2,354.72 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,491.27 | 2,542.03 | 2,372.17 | 2,044.94 | 2,286.83 | 2,354.72 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 131.53 | 164.44 | 164.77 | 162.65 | 216.07 | 175.92 |
| Total Income | 2,622.80 | 2,706.47 | 2,536.94 | 2,207.59 | 2,502.90 | 2,530.64 |
| Total Expenditure | 1,840.23 | 1,771.35 | 1,751.69 | 1,748.15 | 1,629.00 | 1,714.43 |
| PBIDT | 782.57 | 935.12 | 785.25 | 459.44 | 873.90 | 816.21 |
| Interest | 15.51 | 12.75 | 12.79 | 16.91 | 21.00 | 17.18 |
| PBDT | 767.06 | 922.37 | 772.46 | 442.53 | 852.90 | 799.03 |
| Depreciation | 60.91 | 58.59 | 58.89 | 91.64 | 67.61 | 61.30 |
| Tax | 124.39 | 123.56 | 109.34 | 36.75 | 119.88 | 102.38 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -40.38 | -46.51 | -51.93 | 37.20 | -57.71 | -62.23 |
| Reported Profit After Tax | 622.14 | 786.73 | 656.16 | 276.94 | 723.12 | 697.58 |
| Extra-ordinary Items | -31.45 | 63.07 | 45.89 | 51.06 | 46.89 | 55.73 |
| Adjusted Profit After Extra-ordinary item | 653.59 | 723.66 | 610.27 | 225.88 | 676.23 | 641.85 |
| EPS (Unit Curr.) | 52.03 | 65.80 | 54.88 | 23.17 | 60.48 | 58.34 |
| EPS (Adj) (Unit Curr.) | 52.03 | 65.80 | 54.88 | 23.17 | 60.48 | 58.34 |
| Calculated EPS (Unit Curr.) | 52.04 | 65.81 | 54.89 | 23.17 | 60.49 | 58.35 |
| Calculated EPS (Adj) (Unit Curr.) | 52.04 | 65.81 | 54.89 | 23.17 | 60.49 | 58.35 |
| Calculated EPS (Ann.) (Unit Curr.) | 208.16 | 263.23 | 219.54 | 92.66 | 241.95 | 233.40 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 208.16 | 263.23 | 219.54 | 92.66 | 241.95 | 233.40 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 1,850.00 | 0.00 |
| Equity | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 |
| Reserve & Surplus | 0.00 | 13,640.87 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 31.41 | 36.79 | 33.10 | 22.47 | 38.21 | 34.66 |
| PBDTM(%) | 30.79 | 36.28 | 32.56 | 21.64 | 37.30 | 33.93 |
| PATM(%) | 24.97 | 30.95 | 27.66 | 13.54 | 31.62 | 29.62 |
